Pricing Log in Create free account

Bio-Path Holdings, Inc. (BPTH) vs Valion Bio, Inc. (VBIO)

Bio-Path Holdings, Inc. and Valion Bio, Inc. are both Biotechnology companies. Bio-Path Holdings, Inc. and Valion Bio, Inc. are of similar size ($1.1M and $1.1M). Across the 10 metrics below, Bio-Path Holdings, Inc. leads on 8 and Valion Bio, Inc. on 2.

Valuation

Metric BPTH VBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.14 9.40
P/B n/m 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.00 n/m 0.66
EV/Sales n/m 11.09 9.02
Earnings yield 0.00% (40,026.00%) (32.88%)
Free cash flow yield 0.00% (22,510.36%) (23.13%)

Profitability

Metric BPTH VBIO Biotechnology median
Gross margin 0.00% (58.09%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 157.01% (489.30%) (51.96%)
Return on assets (605.50%) (104.96%) (46.06%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric BPTH VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 6.76%
EPS growth (last fiscal year) 87.75% 60.16% 29.88%
Revenue growth, 5-year CAGR — 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTH VBIO Biotechnology median
Debt to equity 0.00 0.62 0.00
Current ratio 0.07 1.11 4.97
Net debt to EBITDA 0.10 0.79 1.01

Dividend

Metric BPTH VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BPTH VBIO Biotechnology median
Market cap 1.07m 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack